Recombinant ferritins for multimodal nanomedicine

Area of Science:

• Biotechnology and Nanomedicine
• Protein Engineering
• Cancer Therapeutics

Background:

• Ferritins are essential proteins for iron homeostasis in all organisms.
• Recombinant ferritins are emerging as key components in multimodal nanomedicine.
• Current research highlights their potential in anticancer treatments and vaccination strategies.

Purpose of the Study:

• To review the utilization of recombinant ferritins in multimodal nanomedicine.
• To emphasize the progress in using recombinant ferritins as nanovaccines, nanozymes, and bioengineered nanocarriers.
• To highlight their application in targeted cancer therapy and bioimaging.

Main Methods:

• Fusion of viral proteins with ferritin subunits to enhance immune response.
• Engineering actively-targeted ferritin nanoparticles for receptor recognition.
• Linking or loading ferritins with contrast agents or fluorescent dyes for theranostics.

Main Results:

• Recombinant ferritin particles improve immune response and antibody titres.
• Targeted ferritin nanoparticles enable specific drug delivery to tumor tissues.
• Ferritin-based multimodal particles serve as effective cancer theranostics.

Conclusions:

• Recombinant ferritins are highly adaptable for multimodal nanomedicine applications.
• Their use as nanovaccines, nanozymes, and drug delivery systems shows significant potential.
• Ferritin-based nanocarriers offer promising avenues for targeted cancer therapy and diagnostics.